HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

GSK Invests In Consumer Unit To Overcome Generic Threat, Low Alli Sales

This article was originally published in The Rose Sheet

  • News

Executive Summary

GlaxoSmithKline expects to overcome increasing generic competition by growing its consumer health business and investing in emerging markets, rather than by pursuing a mega-merger like Pfizer-Wyeth

You may also be interested in...



NanoBio, GSK Leave Rx Drug Path To Take "Remarkable" Cold Sore Med OTC

Privately held biotech company NanoBio's novel cold sore treatment is deviating from the Rx market path most new molecules follow, aiming straight for the OTC market with the help of GlaxoSmithKline

NanoBio, GSK Leave Rx Drug Path To Take "Remarkable" Cold Sore Med OTC

Privately held biotech company NanoBio's novel cold sore treatment is deviating from the Rx market path most new molecules follow, aiming straight for the OTC market with the help of GlaxoSmithKline

C&D’s Act May Be Hard To Follow For Drug Firms Considering Bolt-Ons

Church & Dwight CEO James Craigie has a few words of wisdom on bolt-on acquisitions, recently a popular buzzword among big pharmas looking for savings

Table

View full table

Tags:
Latest Headlines

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales

Euro Q1 Consumer Health Earnings Preview: Reckitt, Sanofi, Haleon, Bayer

Over The Counter 22 Apr 2024: Helping Consumers ‘Tune In’ To Reliable Health Information, With Kaizo PR's Anita Nahal

See All
UsernamePublicRestriction

Register

RS015961

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By